Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
PD-L1-targeted CAR-T immunotherapy
DRUG CLASS:
PD-L1-targeted CAR-T immunotherapy
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
VaxCAR2301 (0)
anti-PD-L1 CSR T cells (0)
gPD-L1 CAR-T (0)
zeushield cytotoxic T lymphocyte therapy (0)
VaxCAR2301 (0)
anti-PD-L1 CSR T cells (0)
gPD-L1 CAR-T (0)
zeushield cytotoxic T lymphocyte therapy (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
PD-L1 expression
Gastric Cancer
PD-L1 expression
Gastric Cancer
PD-L1-targeted CAR-T immunotherapy
Sensitive: D – Preclinical
PD-L1-targeted CAR-T immunotherapy
Sensitive
:
D
PD-L1-targeted CAR-T immunotherapy
Sensitive: D – Preclinical
PD-L1-targeted CAR-T immunotherapy
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login